BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q2 2025 Earnings Call Transcript August 4, 2025
BioCryst Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.15, expectations were $0.03.
Operator: Good day, and welcome to the BioCryst Second Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to John Bluth. Please go ahead.
John D. Bluth: Thank you very much. Good morning, and...
